Approval of Capital Reduction (Free Reduction) to Cover Deficits - 25.8% Attendance, 93.3% Approval
- Proposal for capital reduction (free reduction) to cover deficits was approved at the extraordinary general meeting
- Attendance 25.8% of total voting shares, approval rate 93.3%, opposition/abstention 6.7%
- The free reduction reduces number of shares without compensation to shareholders, aiming to improve financial structure
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Result of Extraordinary General Meeting of Shareholders
- Company: Telcon RF Pharmaceutical (200230)
- Submission: Telcon RF Pharmaceutical. Inc.
- Receipt: 05-21-2026
- Under KRX KOSDAQ Market Division